Filter
1111
Filtered Results: 1111
Text search:
vaccine
trial
Featured
Recommendations
139
New Publications
237
Language
Document type
No document type
479
Studies & Reports
208
Guidelines
192
Manuals
68
Fact sheets
65
Strategic & Response Plan
41
Situation Updates
18
Training Material
14
Resource Platforms
12
Infographics
6
Videos
5
Brochures
2
App
1
Countries / Regions
Global
51
India
37
Kenya
26
Sierra Leone
25
South Africa
23
Liberia
21
Nigeria
21
West and Central Africa
18
Ethiopia
17
Western and Central Europe
17
Brazil
16
East and Southern Africa
16
Uganda
14
Africa
14
Latin America and the Carribbean
13
Congo, Democratic Republic of
11
Eastern Europe
11
Russia
10
Guinea
9
Ghana
9
Zambia
9
Ukraine
9
South Sudan
8
Rwanda
8
Malawi
8
Philippines
7
Nepal
7
Germany
7
Tanzania
7
Mozambique
7
Middle East and North Africa
7
South–East Asia Region
7
Zimbabwe
6
Syria
6
Bangladesh
6
Cambodia
4
Namibia
4
Myanmar / Burma
4
Asia
4
Vietnam
4
Burkina Faso
3
Senegal
3
USA
3
Lebanon
3
Thailand
3
Indonesia
3
Chile
3
Eastern Europe and Central Asia
3
Paraguay
3
United Kingdom
3
Guinea-Bissau
2
Cameroon
2
Jordan
2
Turkey
2
China
2
Sudan
2
Argentina
2
Botswana
2
Angola
2
Lesotho
2
Spain
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Niger
1
Haiti
1
Pakistan
1
Iraq
1
Gambia
1
Malaysia
1
Papua New Guinea
1
Central African Republic
1
Peru
1
Eswatini/ Swaziland
1
Honduras
1
Ecuador
1
Yemen
1
Western Pacific Region
1
Venezuela
1
Southern Africa
1
Laos
1
Bulgaria
1
Gabon
1
Japan
1
France
1
Tunisia
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
296
Clinical Guidelines
145
Women & Child Health
64
Public Health
58
Key Resources
23
Pharmacy & Technologies
14
Capacity Building
4
Toolboxes
COVID-19
282
TB
91
HIV
81
Ebola
67
Rapid Response
55
NTDs
44
AMR
31
Pharmacy
26
Global Health Education
16
Refugee
15
Mental Health
15
Planetary Health
14
Health Financing Toolbox
14
Conflict
12
NCDs
12
Polio
11
Zika
11
Caregiver
11
Cholera
10
Disability
2
Natural Hazards
1
This article is part four in a series of explainers on vaccine development and distribution
Available in different languages
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this ..., epidemics due to Neisseria meningitidis serogroup A (NmA) are disappearing, but other serogroups (e.g. NmW, NmX and NmC) still cause epidemics, albeit at a lower frequency and of a smaller size. Due to these changes, WHO organized the review of the evidence to provide recommendations for epidemic control, related to operational thresholds for investigation and response to outbreaks, the use of rapid diagnostic tests, antibiotic regimens in epidemics, and prophylaxis for household contacts of cases
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i...
This training module is designed to equip health workers (HWs) with
knowledge, skills, confidence and resources to help them in their role to recommend the Human Papillomavirus
(HPV) vaccine.
31 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained ...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vac...
In the current absence of vaccine for COVID-19, public health response target breaking the chain of infection by focusing on the mode of transmission. This paper summarizes current evidence-base around the transmission dynamics, pathogenic, and clin...
Immunization in the context of COVID-19 pandemic
recommended
Immunizations are an essential health service that protect susceptible individuals from vaccine-preventable diseases (VPD).2 By providing timely immunizations, individuals and communities remain protected and the likelihood of a VPD outbreak decreas...
This guide is intended to support national governments developing their national deployment and vaccination plans (NDVPs) for COVID-19 vaccines by outlining the roles, needs and opportunities for community health workers (CHWs) to contribute. This note builds on and is structured to align with the G...
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
31 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained ...
Tackling COVID-19 misinformation. Ensuring communities have access to lifesaving public health information from trusted sources and are not misled by misinformation is essential to ending the COVID-19 pandemic.
In an effort to empower doctors and nurses – some of the most effective and trusted...
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine developm...
Introduction: Considering the global prevalence of coronavirus disease 2019 (COVID-19), a vaccine is being developed to control the disease as a complementary solution to hygiene measures—and better, in social terms, than social distancing. Given ...
The WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination is intended to offer guidance on the prioritization of groups for vaccination when vaccine supply is limited. It provides a values foundation for the object...
The COVID-19 pandemic has raised profound ethical challenges on an unprecedented global scale. These challenges include how to allocate scarce resources (especially vaccines and therapeutics), both within and between countries, whether and when to mandate vaccines and/or masks, whether and how to co...
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendations on building and restoring confidence in vaccines ...
It is estimated that around 2 billion people worldwide do not have access to essential medicines. Access to medicines in the Eastern Mediterranean Region varies among countries, depending on their income level and allocation of domestic resources to medicine and ... procurement. Access to safe and effective antibiotics remains a major challenge, especially for low- and middleincome countries. Barriers to access include high prices for new products, weak regulatory systems, substandard and falsified antibiotics, shortages of essential antimicrobials and inefficient procurement and supply management systems.
COVID-19 Vaccination & Communication
recommended
March 9, 2021
Here you can find a collection of useful manuals, videos, infographics and resource platforms.
The category "Vaccine hesitancy & myths" will be updated regularly with new documents, videos and information material. Please check this ...
The 2014–2015 Ebola epidemic in western Africa was the longest and most deadly Ebola epidemic in history, resulting in 28,616 cases and 11,310 deaths in Guinea, Liberia, and Sierra Leone. The Ebola virus has been known since 1976, when two separate outbreaks were identified in the Democratic Repub...
